skip to Main Content

Qualcomm’s loss in IP licensing

INTRODUCTION: Qualcomm faced a setback from the US federal trade commission after it ruled that the latter is making undue advantage of its dominant position in the field of chip manufacturing, an essential part of cell phones. US District Court…

Impact Of Medimmune Case

Introduction The MedImmune case[1] arose when MedImmune, a pharmaceutical manufacturing company, challenged the validity of Cabilly patent II granted to Genentech, a biotechnology corporation. MedImmune had signed an agreement with Genentech, which was the patent holder, to license the Cabilly…

Back To Top